Research Article
Anticoagulant Utilization and Cost Analysis among Cardiology Inpatients in a Tertiary Care Teaching Hospital of Western Nepal
Table 2
Anticoagulant use and cost in the cardiology unit (n = 132).
| | Characteristics | Categories | n (%) |
| | Prescribed anticoagulants | Unfractionated heparin (UFH) | 4 (3.03) | | Unfractionated heparin + enoxaparin | 60 (45.45) | | Enoxaparin | 36 (27.3) | | Enoxaparin + warfarin | 21 (15.90) | | Warfarin | 6 (4.54) | | Dabigatran | 5 (3.78) | | Indication of anticoagulants use | Acute coronary syndrome (ACS) | 88 (66.67) | | Congestive heart failure (CHF) | 40 (30.30) | | Rheumatic heart disease (RHD) | 4 (3.03) | | †Individual drug cost | $0.03 to $126.24 | $79.92 ($46.32) |
|
|
†Median (IQR) instead of n (%); IQR: interquartile range. 1$ (USD) = 114.05 Nepalese rupees (NRs) during the study period.
|
